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Abstract
SAM and SH3 domain-containing protein 1 (SASH1) was previously described 
as a candidate tumor suppressor gene in breast cancer and colon cancer to mediate 
tumor metastasis and tumor growth. However, the underlying mechanism that 
SASH1 implements breast cancer metastasis in most solid cancers remains unex-
plored. In this study, SASH1 was identified to bind to IQ motif-containing GTPase 
activating protein 1 (IQGAP1). In breast cancer tissues, there was a correlation 
between the expressions of SASH1 and IQGAP1 (P < 0.05), and the expressions 
of SASH1 and IQGAP1 proteins were, respectively, correlated with the expression 
of E-cadherin (P < 0.001). In addition, the expressions of SASH1 and IQGAP1 
proteins were correlated with tumor diameter and tumor grade (all P < 0.05) but 
without lymph node metastasis (P > 0.05). Therefore, it is suggested that SASH1 
may form a new signaling cascade with IQGAP1 and E-cadherin to regulate breast 
cancer metastasis.
Keywords: breast neoplasms, gene expression regulation, cadherins, SAM and 
SH3 domain-containing protein 1 (SASH1), IQ motif-containing GTPase activating 
protein 1 (IQGAP1)
1. Introduction
Breast neoplasm is the most common cancer in women, which is originated 
from mammary epithelial tissue. The age of breast cancer is about 40–60 years old 
or before and after menopause. The morbidity of breast cancer is showed to be an 
upward trend year by year [1]. There are many factors that trigger breast cancer; 
however, the genetic factors only account for 10 and 90% of inducing factors of 
breast cancer remain to be investigated. SASH1 is a novel tumor suppressor gene, 
which is located in chromosome 6q24.3 [2] and is expressed in most of human tis-
sues and cells except for lymphocytes and dendritic cells [3]. SASH1 was originally 
identified as a candidate tumor suppressor gene in breast cancer and colon cancer, 
regulating tumorigenesis of breast and other solid cancers and the adhesive and 
migratory behavior of cancer cells in tumor formation [4, 5]. Compared with that 
in normal breast epithelial tissues, SASH1 is downregulated in 74% of epithelial 
tissues of breast cancer-affected individuals [4, 6]. Some studies indicate that 
SASH1 downregulation is associated with tumor metastasis [3, 5]. Other studies 
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indicate downregulated SASH1 promotes metastasis of hepatoma carcinoma cells 
through Shh signal pathway [7].
IQGAP1 is a scaffolding protein with 189 kDa of molecule weight, which 
contains multiple protein-interacting domains, such as a calponin homology 
domain, a polyproline-binding domain, four calmodulin-binding motifs, and a Ras 
GAP-related domain [8, 9]. The binding players of IQGAP1 proteins are involved 
in actin, calmodulin, members of the Rho GTPase family (i.e., Rac1 and Cdc42), 
Rap1, E-cadherin, β-catenin, members of the mitogen-activated protein kinase 
(MAPK) pathway, and adenomatous polyposis coli [8, 10]. Various basic cellular 
activities such as cytoskeletal organization, cell-cell adhesion, cell migration, 
transcription, and signal transduction are mediated by the bindings of IQGAP1 to 
these proteins [11]. Cell-cell adhesion of epithelial cells is predominantly mediated 
by E-cadherin and the associated catenin complex [12], which includes α-catenin 
(102 kDa), β-catenin (92 kDa), and γ-catenin/plakoglobin (83 kDa). β-Catenin 
combines with E-cadherin, and α-catenin links this E-cadherin/β-catenin com-
plex to the actin cytoskeleton, which is essential for E-cadherin to express its full 
adhesive function. Remodeling of this adhesive sequence leads to cell detach-
ment or loosening of cell-cell contact, which promotes epithelial cells to move as 
clusters, and IQGAP1 is involved in the remodeling of the adhesive complexes of 
epithelial cells [11, 13–15]. Our previous studies suggest that SASH1 is associated 
with MAP2K2 to cross talk with ERK1/2-CREB cascade to trigger melanin syn-
thesis in the formation of hyperpigmentation plaques of a kind of dyschromatosis 
[16]. Importantly, our previous studies also indicate that SASH1 not only bind 
to G alpha S protein (Gαs) but IQGAP1 to form a novel Gαs-SASH1-IQGAP1-E-
cadherin cascade and mutated SASH1(s) which mediate E-cadherin expression 
through the Gαs-SASH1-IQGAP1-E-cadherin cascade to promote directional 
migration of melanocytes or melanoma cells [17]. So, it is speculated that this 
mechanism may also exist in breast cancer cells. Taken above, the associations 
between SASH1 and IQGAP1 in breast cancer cells and the expression of SASH1, 
IQGAP1, and E-cadherin were analyzed by immunohistochemistry analyses in 
80 cases of the affected individuals of breast cancer. Furthermore, the expression 
relationship among SASH1, IQGAP1, and E-cadherin and the associations between 
clinical index of breast cancer patients and the expression of SASH1 and IQGAP1, 
respectively, were assessed to find out novel interference targets for early preven-
tion of breast cancer metastasis.
2. Material and methods
2.1 Plasmid construction of HA-IQGAP1-pcDNA3.0 and pEGFP-C3-SASH1
The construction of pEGFP-C3-SASH1 recombined vectors was mainly 
referred to our previous description [17]. IQGAP1 cDNA was obtained from 
Han Jiahuai Lab, Xiamen University (Xiamen, Fujian, China), and cloned into 
pcDNA3.0-HA vector. PCR was performed with IQGAP1 cDNA as template 
using TransTaq® DNA Polymerase High Fidelity (TransGen Biotech, Ltd., 
Beijing, China) using the following cloning primers of IQGAP1: sense primer, 
5’-TAGTCTAGAAT GTCCG CCGCAACGAG-3’(Xba I inserted) and antisense 
primer, 5′-CCGCTCGAGTTACTTCCCGTAGAACTTTTTG-3′ (Xho I inserted). 
The amplification conditions were as follows: 95°C 2 min, 95°C 30 s, 58°C 30 s, and 
72°C 1 min for 30 cycles and 72°C 5 min and 4°C forever. The recombined vec-
tors were identified by enzyme digestion of endonuclease and CDS of SASH1 and 
IQGAP1 genes.
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2.2 Cell culture and transfection
Human breast cancer cell lines including SK-BR-3 cells were obtained from the 
Cell Bank of Chinese Academy of Sciences (Shanghai, China). After several times 
of passage, cells were used and cultured in Dulbecco’s Modified Eagle’s medium 
(DMEM) (Gibco, Logan, UT), containing 10% BI fetal bovine serum (Bioind, 
Israel) and 1% penicillin-streptomycin solution at 37°C with 5% CO2. SK-BR-3 
cells were subcultured for three times and cultured to logarithmic growth phase 
for plasmid transfection. The HA-IQGAP1-pcDNA3.0 and pEGFP-C3-SASH1 
were transfected into SK-BR-3 cells according to different combinations using PEI 
prepared by us. The transfected SK-BR-3 cells were divided into three groups, that 
is, two single-vector transfection groups and one double-vector transfection group. 
At 48 h after transfection, the transfected SK-BR-3 cells were lysed and collected for 
immunoprecipitation assays.
2.3 Immunoprecipitation and immunoblotting
Transfected SK-BR-3 cells were gently washed in PBS three times and then 
lysed for 25 min using IP-WB lysis buffer (Beyondtime Inc. Ltd., Jiangsu, China) 
with complete protease inhibitor cocktail per 10-cm dish for 20 min on ice. The cell 
lysates were transferred to 1.5 ml microcentrifuge tubes. The extracts were centri-
fuged for 15 min at 12,000 rpm at 4°C. The supernatants were immunoprecipitated 
using GFP mouse monoclonal antibody (T0005, Affinity Biosciences, Cincinnati, 
OH, USA) or HA mouse monoclonal antibody (mAb) (Abmart, Shanghai, China) as 
performed in our previous descriptions [17]. The immunoprecipitates were washed 
with PBS for three times and subjected to western blotting as previously described 
[16, 17]. Most of the western blots were mainly performed in our previous reports 
[17]. The associated HA-IQGAP1 or GFP-SASH1 was detected by western blot along 
with β-tubulin as loading control. The primary antibodies used in western blot were 
as follows: anti-GFP, anti-HA, and anti-β-tubulin (10B1) mouse mAb (EarthOx Life 
Science, Millbrae, CA, USA or Shanghai Genomics, Shanghai, China).
2.4 Clinical cases
All breast cancer patients who underwent surgery were followed by treatment 
in accordance with the National Comprehensive Cancer Network clinical practice 
guidelines. Fresh primary breast cancer tissues and some of the corresponding 
adjacent tissues were collected from 80 breast ductal carcinoma patients under-
going resection from May 2015 to June 2016 at the Chongqing Cancer Hospital. 
Histological diagnosis and tumor-node-metastasis staging of cancer were deter-
mined in accordance with the American Joint Committee on Cancer manual criteria 
for breast cancer. Written informed consent regarding tissue and data used for 
scientific purposes was obtained from all participating patients. The study was 
approved by the Research Ethics Committees of the affiliated Hospitals of Guizhou 
Medical University and Chongqing Cancer Hospital. All of the breast cancer cases 
were diagnosed by pathological examinations (HE staining and immunohisto-
chemistry analyses). In the clinical cases of breast cancer, 26 cases are with lymph 
node metastasis, 51 cases are without lymph node metastasis, and 3 cases could not 
acquire the information of lymph node metastasis. Breast tumor diameters of 16 
cases were <1 cm, those of 41 cases were 1.1–2 cm, those of 18 cases were 2.1–3 cm, 
and those of 5 cases were >3 cm. According to WHO histological classification of 
breast tumors (2003), 80 cases of breast invasive ductal carcinoma were graded his-
tologically in terms of duct formation, nuclear pleomorphism, and mitosis. Among 
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the 80 cases of breast invasive ductal carcinoma, 65 cases were graded into 3 grades: 
8 cases belonged to grade I, 47 cases to grade II, and 10 cases to grade III.
2.5 Immunohistochemical analyses of SASH1, IQGAP1, and E-cadherin
The breast cancer tissues obtained from surgical operation were fixed at 4°C in 10% 
formaldehyde solution for 24 h. The excess fat and other tissues of breast cancer tissues 
were removed and embedded with paraffin and made into 5 millimeter (mm) tissue 
sections. The tissue sections (5 mm) were baked at 56°C and dehydrated and subjected 
to peroxidase blocking. Tissues of human breast cancer and corresponding adjacent 
tissues were immunohistochemically stained with SASH1 rabbit polyclonal antibody 
(pAb) (A302-265A-1, Bethyl Laboratories, Inc., Texas, USA, or Novus Biologicals, 
USA), IQGAP1 rabbit polyclonal antibody (Bethyl Laboratories, Inc., Texas, USA), and 
E-Cadherin (24E10) Rabbit mAb (#3195, Cell Signaling Technology). Primary anti-
bodies were added and incubated at 37°C and then for overnight at 4°C. After washing 
three times for 10 min each with TBS, the sections were incubated with horseradish 
peroxidase-conjugated anti-rabbit and anti-mouse universal secondary antibodies 
for 30 min at 37°C. Subsequently, the sections were counterstained with hematoxylin 
mounted, observed, and photographed under the positive position microscope BX51 
at a 100× magnification or a 400× magnification. Finally, the stained slides were 
observed under a microscope, and images were acquired [17]. The experimental 
protocols were mainly referred to our previous description [17].
According to the staining intensity of tumor cells, the three proteins, SASH1, 
IQGAP1, and E-cadherin, were scored and divided into four grades: 0 score (−), 
1 score (+), 2 score (++), and 3 score (+++). The three proteins were also scored 
according to positive cells’ percentage of the three proteins and divided into six 
grades: 0 score (<1%), 1 score (1–20%), 2 score (21–40%), 3 score (41–60%), 4 
score (61–80%), 5 score (81–100%). Based on the staining intensity of SASH1, 
IQGAP1, and E-cadherin, the staining intensity and positive cells’ percentage of 
three proteins were calculated as in our previous description [16]. Total scores of 
each visual field were determined by the formula: staining intensity scores of posi-
tive cells × scores of positive cells’ percentage = total scores of each view fields.
2.6 Statistical analyses
All of experimental results were repeated for three times and statistically 
analyzed using SPSS 16.0 statistical software. Chi square test was performed to 
analyze the IHC results of breast cancer tissues and the relationship between 
expression of SASH1 and IQGAP1 and clinical indicators. Rank-sum test was used 
to assess the grading relationship between the SASH1 and E-cadherin and IQGAP1 
and E-cadherin, respectively. Spearman correlation coefficient method was used 
to assess the correlation between expressed scores of SASH1 and E-cadherin and 
IQGAP1 and E-cadherin, respectively. The data are indicated as mean ± standard 
error of the mean (SEM), and the difference was statistically significant with 
P < 0.05. Cartograms were plotted with GraphPad Prism 5.
3. Results
3.1 SASH1 is associated with IQGAP1
To identify the associations between SASH1 and IQGAP1, HA-IQGAP1-pcDNA3.0 
and pEGFP-C3-SASH1 were constructed and were singly or combinedly transfected 
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into SK-BR-3 cells and immunoprecipitation; western blot (IP-WB) was performed 
to identify the associations between exogenous SASH1 and exogenous IQGAP1. 
HA-IQGAP1 and GFP-SASH1 were singly or in pair transfected into SK-BR-3 cells at 
48 h posttransfection, the transfected cells were lysed, and HA-IQGAP1 was immu-
noprecipitated, and the associated GFP-SASH1 was detected by GFP antibody. The 
associated HA-IQGAP1 and GFP-SASH1 in the immunoprecipitates and cell lysates 
(input) were confirmed by western blot. Meanwhile, GFP-SASH1 and HA-IQGAP1 
were also either single or in pair transfected into SK-BR-3 cells and after 48 h of trans-
fection, the transfected cells were lysed and were GFP-SASH1 was immunoprecipi-
tated and the associated HA-IQGAP1 was detected by HA antibody. The associated 
GFP-SASH1 and HA-IQGAP1 in the immunoprecipitates and cell lysates (input) were 
identified by western blot. Finally, our IP-WB analyses confirmed that exogenous 
SASH1 was associated with exogenous IQGAP1 (Figure 1).
3.2  There was a positive correlation between SASH1 and IQGAP1 expression in 
breast cancer tissues
IHC analyses confirmed that the positive staining of SASH1 and IQGAP1 
protein was light brown in breast cancer tissues, the cell nucleus was purple, and 
the distribution of SASH1 and IQGAP1 was located in the same sites of breast 
cancer tissues. SASH1 and IQGAP1 show the same or similar expression tendency 
in breast cancer tissues, i.e., low level of SASH1 expression is followed by low 
level of IQGAP1 expression and high expression of SASH1 is accompanied by 
high expression of IQGAP1 (Figure 2A). A total of 80 breast cancer tissues were 
divided into four groups according to the median value of SASH1 and IQGAP1 
protein expression scores: SASH1 scores <1.23 were considered as low expression, 
SASH1 scores ≥1.23 were considered as high expression, IQGAP1 scores <0.78 
were maintained as low expression, and SASH1 scores ≥0.78 were maintained 
as high expression. Statistical analyses indicated that in the 80 cases of breast 
cancer tissues, cases with low SASH1 expression accounted for 56.3% (45/80) 
and the cases with low IQGAP1 expression were more than those of high IQGAP1 
Figure 1. 
SASH1 is associated with IQGAP1. (A) GFP-SASH1 and HA-IQGAP1 were singly or in pair transfected into 
SK-BR-3 cells, and at 36 h after transfection, the transfected cells were lysed and collected for IP-WB analyses. 
HA-IQGAP1 was immunoprecipitated, and the associated GFP-SASH1 was detected by western blot using 
GFP antibody. GFP-SASH1 and HA-IQGAP1 in the cell lysates (input) were detected by western blot along 
with β-tubulin with loading control. (B) HA-IQGAP1 and GFP-SASH1 were singly or in pair transfected into 
SK-BR-3 cells, and at 36 h after transfection, the transfected cells were lysed and collected for IP-WB analyses. 
GFP-SASH1 was immunoprecipitated, and the associated GFP-SASH1 was detected by western blot using GFP 
antibody. HA-IQGAP1 and GFP-SASH1 in the cell lysates (input) were analyzed by western blot along with 
β-tubulin with loading control.
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expression (>65%, P = 0.015) (Figure 2B). And statistical analyses also suggested 
that in the 80 cases of breast cancer tissues, cases with low IQGAP1 expression 
accounted for 58.8% (47/80) and the cases with low IQGAP1 expression were 
more than those of high IQGAP1 expression (>60%, P = 0.011) (Figure 2B). 
Meanwhile, the IHC detection results of SASH1 and IQGAP1 were scored and 
analyzed by Spearman correlation analyses, and the scores of SASH1 and IQGAP1 
were plotted by GraphPad Prism 5 software. In 80 cases of breast cancer tissues, 
except for 5 cases, SASH1 scores and IQGAP1 scores in most of cases closely 
Figure 2. 
SASH1 expression in 80 cases of breast cancer tissues which is positively correlated with IQGAP1. (A) The 
expressions of SASH1 and IQGAP1 in 80 cases of breast cancer tissues were detected by immunohistochemical 
staining method. The cell nucleus was dyed purple and SASH1 and IQGAP1 were dyed pale brown. The 
left panels were HE staining, and the middle panels and the right panels were IHC staining of SASH1 and 
IQGAP1. The figures in upper panels were 100× magnification, and one region in the 100× magnification 
figures was amplified for 400× and framed in black and showed in the bottom panels. (B) The expressions of 
SASH1 and IQGAP1 were scored, and the score results of SASH1 and IQGAP1 were plotted with GraphPad 
Prism 5 and analyzed by χ2 test. The analysis results of SASH1 and IQGAP1 expressions in the left panel 
indicated that when SASH1 expression was low, the positive percentage of low expressed IQGAP1 was much 
more than that of high expressed IQGAP1. The expression of SASH1 showed significantly positive correlation 
with that of IQGAP1 (P = 0.015). And the statistical analyses also suggested that when IQGAP1 expression was 
low, the positive percentage of low expressed SASH1 was much more than that of high expressed SASH1. The 
expression of IQGAP1 demonstrated significantly positive correlation with that of SASH1 (P = 0.011).  
(C) The expressions of SASH1 and IQGAP1 were scored, and the score results of SASH1 and IQGAP1 were 
plotted with GraphPad Prism 5 and analyzed by Spearman correlation coefficient analyses. Spearman 
correlation coefficient analyses indicated that except for two score values of SASH1, expression of SASH1 and 
IQGAP1 showed good similar or same tendency of changes (P = 0.004).
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intersected, which indicated that the SASH1 expression and IQGAP1 expression 
showed significantly positive correlation (r = 0.308, P = 0.004) (Figure 2C).
3.3  The expression of SASH1 and IQGAP1 protein in breast cancer was 
significantly correlated with tumor size and tumor grade
It has been known that the expression of SASH1 and IQGAP1 is associated with 
tumor metastasis. So, in this study, we further identify the relationship of expression 
of SASH1 and IQGAP1 with clinical data of breast cancer-affected individuals. Our 
analyses (Table 1) indicated that in 77 cases of breast cancer with lymph node dis-
section, the low expression rate of SASH1 protein in lymph node metastasis positive 
group was slightly higher than that in lymph node metastasis negative group. The low 
Clinical parameters Total SASH1 IQGAP1 P
Low High Low High
Lymph node metastasisa >0.05
Positive 26 17 9 15 11
Negative 51 28 23 30 21
Tumor diameter/cmb <0.05
≤1 16 8 8 10 6
1.1–2 41 24 17 23 18
2.1–3 18 9 9 10 8
>3 5 4 1 4 1
Histological gradec <0.01
I 8 4 4 6 2
II 47 26 21 24 23
III 10 7 3 7 3
aN = 77.
bN = 80.
cN = 65.
Table 1. 
Association of SASH1 and IQGAP1 expressions with the clinical parameters of breast cancer patients (n).
E-cadherin SASH1 IQGAP1
− + ++ ++ Totala − + ++ +++ Totalb
− 4 6 6 1 17 8 8 1 0 17
+ 6 20 2 0 28 12 12 4 0 28
++ 5 25 3 0 33 12 19 2 0 33
+++ 1 0 1 0 2 1 1 0 0 2
Total 16 51 12 1 80 33 40 7 0 80
ar = 0.461, P < 0.001.
br = 0.454, P < 0.001; by rank-sum test.
Table 2. 
Correlation of SASH1 and IQGAP1 expressions with E-cadherin expression rankin breast cancer tissues  
(n, N = 80).
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expression rate of IQGAP1 protein was slightly lower than that of the negative lymph 
node metastasis group, but the difference was not statistically significant (65.4% 
vs. 54.9%, 57.7% vs. 58.8%, all P value > 0.05). In 80 cases of breast cancer, the low 
expression rate of SASH1 protein was 50.0, 58.5, 50.0, and 80.0%, respectively, in 
patients with tumor diameter <1.0 cm, 1.1–2.0 cm, 2.1–3.0 cm, and >3.0 cm. The low 
expression rates of IQGAP1 protein were 62.5, 56.1, 55.6, and 80.0%, respectively. 
There were significant differences between the two groups (P < 0.05). In 65 cases 
of breast cancer with histological grading data, the low expression rates of SASH1 
protein in histological grading I, II, and III were 50.0, 55.3, and 70.0%, respectively. 
The low expression rates of IQGAP1 protein were 75.0, 51.1, and 70.0%, respectively. 
There were significant differences between groups (P < 0.01).
3.4  The expression of SASH1 and IQGAP1 is positively related with E-cadherin, 
respectively, in breast cancer tissues
SASH1 and IQGAP1 have been identified to be involved in tumor metastasis. 
And immunohistochemistry (IHC) analyses were performed to detect the expres-
sion of E-cadherin in breast cancer tissues and the relevance of E-cadherin with 
SASH1 and IQGAP1, respectively. IHC analyses indicated that E-cadherin was 
mainly located in the cytoplasma membrane of breast cancer tissues. According 
to the positive intensity of E-cadherin staining, E-cadherin protein expression 
in breast cancer tissues was graded to four grades, and meanwhile the positive 
intensity of SASH1 protein staining was also graded to four grades. Statistical 
analyses suggested that expression of SASH1 protein was significantly positive 
related to that of E-cadherin (r = 0.461, P < 0.001 (Table 2 and Figure 3)).  
Figure 3. 
SASH1, IQGAP1, and E-cadherin proteins showed consistent changes in the breast cancer tissues.  
The cell nucleus was dyed purple and SASH1, IQGAP1, and E-cadherin were dyed pale brown, and the 
magnification is 200×. According to staining intensity of tumor cells and the numbers of positive cells, the 
immunohistochemical results of SASH1, IQGAP1, and E-cadherin proteins were divided into four grades: 
negative (−), weakly positive (+), moderately positive (++), and strongly positive (+++). The expression 
of SASH1 was positively correlated with that of E-cadherin and the expression of IQGAP1 show positive 
correlation with that of E-cadherin. The cell nucleus was dyed purple, and SASH1, IQGAP1, and, E-cadherin 
were dyed pale brown, and the magnification is 200×.
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SASH1 and E-cadherin staining intensity was moderately positive staining 
intensity, respectively, which was defined low expression. And further statisti-
cal analyses suggested SASH1 and E-cadherin were downregulated in 77 cases 
(77/80, 96.25%) of breast cancer tissues. All of these indicated that the low 
expression of SASH1 and the low expression of E-cadherin protein in breast 
cancer tissue are in good agreement.
According to the staining intensity of IQGAP1 protein and E-cadherin protein 
in 80 cases of breast cancer, the staining intensity of E-cadherin and IQGAP1 
was divided into four grades. Statistical analyses demonstrated that expression of 
IQGAP1 protein was significantly positive related to that of E-cadherin (r = 0.454, 
P < 0.001 (Table 2 and Figure 3)). Staining intensity of IQGAP1 and E-cadherin 
was moderately positive staining intensity, respectively, which was defined low 
expression. And further statistical analyses suggested IQGAP1 and E-cadherin were 
both downregulated in 78 cases (78/80, 97.5%) of breast cancer tissues. All of these 
indicated that the low expression of IQGAP1 and the low expression of E-cadherin 
showed better consistency in breast cancer tissue.
4. Conclusion
Clinical research indicates that occurrence of breast cancer is associated with 
many factors including genetic factors, environment, and lifestyle. SASH1, a 
tumor suppressor gene, is downregulated in most of neoplasms. Decrease or dele-
tion of SASH1 expression is closely related to tumor metastasis [4, 5, 18]. It has 
been reported that the expression of SASH1 protein in osteosarcoma tissues with 
lung metastasis is significantly lower than that in osteosarcoma tissues without 
lung metastasis [19]. Upregulated SASH1 can significantly suppress the migration 
of cervical carcinoma Hela cells, and, in contrast, knockdown of SASH1 signifi-
cantly results in reduced adhesion ability of human colon cancer SW480 cells 
and mouse rectal cancer CMT-93 cells and enhanced migration ability of these 
tumor cells [3]. Downregulation of SASH1 protein expression in thyroid tumor 
cells may play an important role in thyroid tumor metastasis [20]. SASH1 mRNA 
is downregulated in primary liver cancer and thyroid cancer [5]. Compared with 
corresponding normal tissues, SASH1 protein is downregulated in 37 cases among 
50 cases of breast cancer tissues and SASH1 expression loss is associated with 
breast cancer metastasis [4]. All of these studies suggest that expression loss of 
SASH1 medicates tumor metastasis. In this study, our IHC analyses identified that 
in 80 cases of breast cancer tissues, low expression of SASH1 protein in 45 cases 
(45/80 56.3%) was found, which indicated that SASH1 was downregulated in 
breast cancer.
IQGAP1 proteins are members of the evolutionarily conserved scaffolding 
protein family and are more widely expressed than other members of the fam-
ily [21, 22]. IQGAP1 interacts with specific proteins such as actin, calmodulin, 
Rho GTPase family members, E-cadherin, and β-catenin. The interactions of 
IQGAP1 with those specific proteins medicate multiple cell activities such as 
cell scaffold, intercellular adhesion, metastasis, invasion, transcription, and cell 
signal transduction. For example, the binding of IQGAP1 to β-catenin to form 
E-cadherin/β-catenin complex inhibits intercellular adhesion of epithelial cells 
and promotes β-catenin-mediated transcriptional activation [9]. IQGAP1 protein 
,which mediates E-cadherin-mediated-intercellular adhesion, is the key molecule 
in cell polarization and directed migration [23]. IQGAP1 expression is showed 
to be of prognostic significance in advanced colorectal carcinoma, and a shorter 
overall survival of colorectal carcinoma patients can be predicted by diffuse 
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expression pattern of IQGAP1 [11]. In this study, IHC analyses indicated, in 80 
cases of breast cancer tissues, IQGAP1 protein level was significantly low in 47 
cases accounting for 58.8%, which suggested that IQGAP1 was downregulated in 
breast cancer.
Multiple endocrine neoplasia type 1 (MEN1) is a dominantly inherited tumor 
syndrome that results from the mutation of the MEN1 gene that encodes protein 
menin. MEN1 is revealed to bind to IQGAP1 and increases E-cadherin/β-catenin 
interaction with IQGAP1 and a novel menin-IQGAP1 pathway that controls cell 
migration and cell-cell adhesion found in endocrine cells [24]. Activated Rac1 and 
Cdc42 can bind to IQGAP1, and the bindings of IQGAP1 and Rac1 as well as Cdc42 
promote cell mobility and polarization [25, 26]. IQGAP1 is both a downstream 
effector and an upstream activator of Cdc42, where active Cdc42 antagonizes 
IQGAP1 dissociation of the cell-cell contacts [27, 28]. Cdc42 inhibits IQGAP1’s role 
in polarized secretion in β-cells or perhaps migration [29]. In this study, IP-WB 
analyses indicated the protein-protein interactions between SASH1 and IQGAP1. It 
has been reported that SASH1 expression suppresses cell proliferation and interacts 
with cytoskeletal proteins, which promotes cell matrix adhesion [3, 4]. Meanwhile, 
other studies have identified that SASH1 is associated with scaffold proteins and 
foster tumor migration [3]. Hence, we speculate that the bindings of SASH1 and 
IQGAP1 co-mediate breast cancer metastasis.
Recurrence or metastasis of breast cancer is the leading cause of breast 
cancer-related death. It has been identified that epithelial-mesenchymal transi-
tion (EMT) plays a pivotal role in tumor metastasis through generation and 
survival of induced circulating tumor cells [30]. One of the EMT functions is 
to downregulate and relocate the epithelial cell adhesion protein including the 
leading actor, E-cadherin [31]. The decreased expression of E-cadherin in breast 
cancer was associated with high pathological grade, tumor volume enlargement, 
lymph node metastasis, and distant metastasis and with disease rehabilitation 
and overall survival time, which indicates that reduced expression or func-
tion loss of E-cadherin promotes breast cancer invasion and migration [32]. A 
dynamic equilibrium of E-cadherin between the E-cadherin-β-catenin-α-catenin 
complex and the E-cadherin-β-catenin-IQGAP1 complex at sites of cell-cell 
contact is proposed. The ratio between these two complexes could determine 
the strength of adhesion [33]. Our previous study found that SASH1 muta-
tions enhanced mutated SASH1 expression, however induced downregulation 
of E-cadherin in epithelial cells of skin [17]. So it is speculated that there is a 
connection between SASH1 and E-cadherin. In this study, SASH1 protein level is 
positively correlated with E-cadherin, and IQGAP1 protein level is also positively 
correlated with E-cadherin, which also identifies the connection between SASH1 
and E-cadherin.
Taken above, we speculate that SASH1 may mediate breast cancer metastasis 
through a novel SASH1-IQGAP1-E-cadherin signal cascade. When SASH1 and 
IQGAP1 protein levels in breast cancer tissues and breast cancer cells were low, the 
protein levels of E-cadherin are also reduced, which causes the reduced cell adhe-
sion ability, the tumor cell ability which is easy to fall off, the enhanced invasion, 
and the tumor cell metastasis ability to distance. The novel findings about SASH1 
will become a novel target to treat breast cancer, which will be conducive to the 
precision and diversification of breast cancer treatment, effectively improving the 
prognosis of patients. In this study, we find that low protein levels of SASH1 and 
IQGAP1 are related to tumor size, and the reduced protein levels of SASH1 and 
IQGAP1 are associated with tumor grading, which provides a new reference for 
the rapid diagnosis of tumor grading and tumor size. And our findings on SASH1 
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and IQGAP1 provide a new and more intuitive basis for determining the operation 
plan and resection range, judging the curative effect of operation and early detec-
tion of tumor metastasis and recurrence. However, in this study we find that low 
expression levels of SASH1 and IQGAP1 are significantly not related to lymph node 
metastasis, which presumably can be related to a small sample size of breast cancer 
tissues. The relationship between SASH1 and IQGAP1 with lymph node metastasis 
needs to be further investigated.
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Acronyms and abbreviations
DMEM Dulbecco’s Modified Eagle’s medium
EMT epithelial-mesenchymal transition
Gαs guanine nucleotide-binding protein subunit-alpha isoforms short
HE staining hematoxylin and eosin staining
IHC immunohistochemical
IQGAP1 IQ motif-containing GTPase activating protein 1
IP-WB immunoprecipitation-western blot
PEI polyethylenimine
pAb polyclonal antibody
SASH1 SAM and SH3 domain-containing 1
SEMs standard error of the means
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